Teresa Cabezon

Title: Teresa Cabezon: Innovator in Hepatitis B Vaccine Development

Introduction

Teresa Cabezon is a prominent inventor based in Rhode-St-Genese, Belgium. She has made significant contributions to the field of immunology, particularly in the development of vaccines for hepatitis B. Her innovative work has led to advancements in vaccine technology, which are crucial for public health.

Latest Patents

Teresa Cabezon holds a patent for "Antigens and methods therefor." This patent describes a composite particle that includes at least two polypeptides corresponding to parts of a protein with biological activity related to hepatitis B surface antigens. The composite particle presents multiple antigenic determinants provided by the S-protein, preS2-protein, or preS1-protein. Additionally, the invention includes a modified hepatitis B surface antigen L protein, which can be used alone or incorporated into composite particles. This innovation aims to improve hepatitis B vaccines, particularly through expression in yeasts such as S. cerevisiae and Hansenula polymorpha.

Career Highlights

Teresa Cabezon has worked at Smithkline Biologicals, S.A., where she has been instrumental in advancing vaccine research and development. Her expertise in immunology and vaccine formulation has positioned her as a key figure in her field.

Collaborations

Throughout her career, Teresa has collaborated with notable colleagues, including Martin Comberbach and Nigel Harford. These partnerships have fostered a collaborative environment that enhances the innovation process in vaccine development.

Conclusion

Teresa Cabezon's contributions to hepatitis B vaccine development exemplify her dedication to improving public health through innovative research. Her work continues to influence the field of immunology and vaccine technology.